Table 1 |
|||
| Protective effects of EOFAZ on HUVECs’ injury induced by ox-LDL | |||
| Groups | Dose (mg/L) | OD570 | Inhibition of cell damage (%) |
| Control | — | 1.85±0.11 | |
| ox-LDL | 100 | 0.98±0.12# # | |
| ox-LDL+EOFAZ | 100+0.1 | 1.25±0.20** | 31.0 |
| 100+0.01 | 1.09±0.25 | 12.6 | |
| ox-LDL+PRA | 100+10 μmol/L | 1.19±0.21* | 24.1 |
# #p < 0.01, compared with the control group; *p < 0.05 and ** p < 0.01, compared with the ox-LDL group.
Shen et al. BMC Complementary and Alternative Medicine 2012 12:174 doi:10.1186/1472-6882-12-174
